PROGRAM
tuesday,
september 22
08:00 - 12:00
Preconference: Educational Workshop
12:45 - 13:15
welcome of participants
13:15 - 13:30
opening remarks
13:30 - 14:15
Plenary – Anna Dewenter
(Institute for Stroke and Dementia Research, Germany)
What’s new?
14:15 - 15:15
Symposium – Imaging Methods
Speakers :
- Nick Fox
- Antonio Valero-Cabré
The order and final participants may vary in the final program.
15:15 - 15:45
Datablitz
15:45 - 16:45
coffee break – poster session
16:45 - 18:00
Symposium – The role of sleep in NDD
Speakers :
- Géraldine Rauchs
- Anders Fjell
The order and final participants may vary in the final program.
19:00
Welcome Reception : Cocktail & Public Event
wednesday,
september 23
09:00 - 10:00
Plenary – Susanne van Veluw
(University of Edinburgh, UK)
CAA: imaging and small vessel pathology
10:00 - 10:20
Coffee Break
10:20 - 11:45
Symposium – Non-AD / polypathology
Speakers :
- Rosaleena Mohanty
- Bàrbara Segura
The order and final participants may vary in the final program.
11:45 - 12:05
Datablitz
12:05 - 13:05
Lunch
13:05 - 14:20
Symposium – Interventions
Speakers :
- Nick Fox
- Antonio Valero-Cabré
The order and final participants may vary in the final program.
14:20 - 15:20
Coffee Break – Poster Session
15:20 - 16:25
Symposium – Omics & Connectomics
Speakers :
- Mario Tranfa
- Alessandra Griffa
The order and final participants may vary in the final program.
16:45
Social activity and Gala
thursday,
september 24
10:00 - 10:30
Coffee Break
10:30 - 11:45
Symposium – AI & ML
Speakers :
- James Cole
The order and final participants may vary in the final program.
11:45 - 12:15
Awards
12:15 - 12:30
Closing remarks
Plenary Sessions
Anna Dewenter
Post-doctoral researcher at the Institute for Stroke and Dementia Research (Germany)
+ INFO
Plenary
Juan Helen Zhou
Director, Centre for Translational MR Research, National University (Singapore)
+ INFO
Plenary
Susanne van Veluw
Professor of Translational Vascular Neuroscience, University of Edinburgh (UK)
+ INFO
Plenary
symposium
1. New imaging techniques and innovative approaches
- #1 Meera Srikrishna
University of Gothenburg, Sweden
« CT-based imaging markers for idiopathic normal pressure hydrocephalus obtained using deep learning: association with MRI-based radiological markers and diagnosis » - #2 Heidi Jacobs
Maastricht University & Massachusetts General Hospital, The Netherlands /USA
« Locus coeruleus imaging to identify
pre-preclinical Alzheimer’s disease » - #3 Mistuko Nakajima
University College London, United-Kingdom
« Differential cortical layer vulnerability in
premanifest Huntington’s disease » - #4 Joana Pereira
Karolinska Institutet, Sweden
« Understanding the role of the neuromodulatory nucleiin brain connectivity in aging and neurodegeneration »
2. AD subtypes and differential diagnosis
- #5 Jacob Vogel
Lund University, Sweden
« An update on Alzheimer’s disease tau subtypes: clinical and biological insights » - #6 Rik Ossenkoppele
VU Amsterdam & Lund University, The Netherlands/Sweden
« AT(N) imaging in atypical variants of Alzheimer’s disease » - #7 Alexandre Bejanin
IIB Sant Pau, Spain
« Neuroimaging of Alzheimer’s and vascular pathologies in Down syndrome » - #8 Gérard Bischof
University Hospital Cologne, Germany
« 18F-PI2620 Tau PET in AD and Non-AD
Neurodegenerative Diseases » - #9 Michela Pievani
RCCS Centro San Giovanni di Dio, Italy
« Brain networks connectivity in AD and FTD »
3. Opportunities and Challenges in Data Sharing in European Neuroimaging
- #10 Julia Neitzel
Erasmus MC University Medical Center Rotterdam, The Netherlands
« Data sharing strategies in the Rotterdam Study » - #11 Oliver Speck
Otto-von-Guericke University Magdeburg, DZNE Magdeburg, Germany
« Opportunities and Challenges in multicenter
MR neuroimaging studies » - #12 Ludovica Griffanti
University of Oxford, United Kingdom
« From ‘big data’ to the clinic: implementing the UK Biobank imaging framework for memory clinic patients » - #13 Lyduine Collij
Amsterdam UMC & Lund University, The Netherlands/Sweden
« From AMYPAD to EuroPAD – creating a multi-cohort preclinical database to model AD disease trajectorie » - #14 Kristine Walhovd
University of Oslo, Norway
« Longitudinal neuroimaging studies- Lifebrain and beyond »
4. The present and future of PET imaging
- #15 Agneta Nordberg
NVS,Center for Alzheimer Research, Division of Clinical Geriatrics, Karolinska Institutet, Sweden
« PET imaging markers in neurodegenerative diseases – the present and future » - #16 Bernard Hanseeuw
Cliniques Universitaires Saint-Luc, UCLouvain, Belgium / Massachusetts General Hospital, Harvard Medical School, USA
« Tau-PET imaging: From research data to Appropriate Use Criteria » - #17 Maura Malpetti
Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, UK
« PET imaging of synaptic health across
neurodegenerative diseases » - #18 Julien Lagarde
Hôpital Sainte-Anne, Université Paris-Cité,
Université Paris-Saclay, France
« PET imaging of neuroinflammation in AD and potential implications in therapeutic trials »
#19 Ruben Smith
Lund University / Skåne University Hospital, Sweden
« LAlpha-synuclein PET imaging »
5. Neuroimaging correlates of biofluids and neuropathology
- #20 Laura Jonkman
Amsterdam UMC, the Netherlands
« MRI signatures of neuropathology » - #21 Valentina Perosa
Massachusetts General Hospital, Harvard Medical School, USA
« Leveraging high-resolution ex vivo neuroimaging to gain insight into the pathophysiology of cerebral small vessel disease » - #22 Marc Suárez-Calvet
Barcelonaβeta Brain Research Center, Spain
« New plasma biomarkers related to PET imaging » - #23 Alexa Pichet Binette
Lund University, Sweden
« Associations between misfolded alpha-synuclein aggregates and Alzheimer’s disease pathology in vivo »
6. Modifiable risk and protective factors and non-pharmacological interventions
- #24 Federica Agosta
Vita-Salute San Raffaele University, Italy
« Amyloid Related Imaging Abnormalities (ARIA) in Amyloid Modifying Therapies: risk factors, symptomatology and monitoring recommendations » - #25 Emrah Düzel
Otto-von-Guericke University Magdeburg, DZNE Magdeburg, Germany
« Targeting dysfunction in episodic memory circuitry in Alzheimer’s disease» - #26 Gaël Chételat
Inserm-Université de Caen, France
« Enhancing Brain Health: The Preventive Potential of Meditation against Neurodegenerative Diseases » - #27 Simon Cox
University of Edinburgh, Scotland
« Dementia and Cognitive Ageing in the Lothian Birth Cohorts » - #28 Eider Arenaza-Urquijo
Barcelona Institute for Global Health, Spain
« From the individual to the environment: understanding cognitive and brain resilience in aging »